CSI Market
Sign In | Register

Aveo Pharmaceuticals Inc (AVEO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AVEO Annual Cash Flow →
A period-by-period view of cash flow from Aveo Pharmaceuticals Inc to Sep 30 2021 helps clarify how Sep 30 2022's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
9 Months 		(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Operating Activities
Income-21.78
Depreciation & amortization0.05
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.55
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation4.16
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.72
Noncash Interest Expense Income Net-
Increase Decrease In Deferred Rent-
Tangible Asset Impairment Charges-
Non Cash Interest Expense-
Increase Decrease In Accrued Contract Research-
Increase Decrease In Tenant Improvement Allowance Receivable Current-
Litigation Settlement Expense-
Increase Decrease In Settlement Liability-
Increase Decrease In Contract With Customer Liability-0.58
Increase Decrease In Trade Receivables-8.91
Increase Decrease In Operating Lease Right Of Use Asset0.10
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities0.77
Increase (Decrease) in Accounts Payable2.33
Increase (Decrease) in Other Accrued Liabilities4.15
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.69
Other Working Capital-0.05
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities6.33
Discontinued operations0.00
Net Cash flow from Operating Activities-10.48
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities25.72
Payments to Acquire Available-for-sale Securities, Debt-8.98
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities16.74
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.60
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Repayments Of Loans Payable-
Proceeds From Issuance Of Common Stock And Warrants Net Of Issuance Costs-
Proceeds From Issuance Of Common Stock And Warrants To Related Parties-
Proceeds From Issuance Of Loan Payable And Warrants-
Proceeds From Issuance Of Common Stock To Related Party-
Proceeds From Issuance Of Common Stock Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.60
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-10.48
Total Cash Flow6.86
4 historic quarters locked

Sign in to unlock the full Aveo Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Aveo Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-22-028635

Figures are derived from filed reports and may be restated. Historical data is subject to revision.